Deferasirox is an oral iron chelator used to manage chronic iron overload in patients receiving long-term blood transfusions. It binds to excess iron, facilitating its excretion and preventing organ damage associated with iron overload. Its therapeutic use is listed as antidotes. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Exjade, Jadenu and Osveral. Its PubChem CID is 214348.
Deferasirox
| CAS No | 201530-41-8 |
|---|---|
| Molecular Formula | C21H15N3O4 |
| Molecular Weight | 373.4 g/mol |
| Synonyms | 4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Deferasirox is an oral iron chelator used to manage chronic iron overload in patients receiving long-term blood transfusions. It binds to excess iron, facilitating its excretion and preventing organ damage associated with iron overload.
The listed CAS number is 201530-41-8.
The listed molecular formula is C21H15N3O4.
The listed molecular weight is 373.4 g/mol.
4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid.
The source lists Exjade, Jadenu and Osveral.